SymbolSTXS
NameSTEREOTAXIS, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
Address710 NORTH TUCKER BOULEVARD,SUITE 110, ST. LOUIS, Missouri, 63101, United States
Telephone+1 314 678-6100
Fax
Email
Websitehttps://www.stereotaxis.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001289340
Description

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The companys mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The companys revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

Additional info from NASDAQ:
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The companys mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The companys revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

2026-08-14 07:08

New Form EFFECT - Stereotaxis, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 9999999995-26-002657 <b>Size:</b> 1 KB

Read more
2026-08-14 07:08

New Form EFFECT - Stereotaxis, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 9999999995-26-002656 <b>Size:</b> 1 KB

Read more
2026-08-13 17:13

New Form 424B3 - Stereotaxis, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001493152-26-037771 <b>Size:</b> 363 KB

Read more
2026-08-11 20:05

(30% Negative) STEREOTAXIS, INC. (STXS) Reports Q3 2026 Financial Results

Read more
2026-08-11 20:01

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Read more
2026-07-20 12:31

University of Szeged Pioneers First Robotic Cardiology Program in Hungary

Read more
2026-07-15 18:26

New Form S-3 - Stereotaxis, Inc. <b>Filed:</b> 2026-07-15 <b>AccNo:</b> 0001493152-26-033398 <b>Size:</b> 663 KB

Read more
2026-07-15 18:22

New Form S-3 - Stereotaxis, Inc. <b>Filed:</b> 2026-07-15 <b>AccNo:</b> 0001493152-26-033396 <b>Size:</b> 1 MB

Read more
2026-07-01 20:00

Director SHAMIR NACHUM 🟢 acquired 43.1K shares of Stereotaxis, Inc. (STXS) Transaction Date: Jul 01, 2026 | Filing ID: 031537

Read more
2026-07-01 20:00

Director Benfer David 🟢 acquired 43.1K shares of Stereotaxis, Inc. (STXS) Transaction Date: Jul 01, 2026 | Filing ID: 031536

Read more